Stockscreener 앱 받기
58.51
2.90%
-1.75
전일 마감가:
$60.26
열려 있는:
$60.57
하루 거래량:
2.26M
Relative Volume:
1.04
시가총액:
$9.12B
수익:
$1.17B
순이익/손실:
$150.71M
주가수익비율:
62.24
EPS:
0.94
순현금흐름:
$245.03M
1주 성능:
-5.14%
1개월 성능:
-4.71%
6개월 성능:
+13.55%
1년 성능:
-23.70%
1일 변동 폭
$58.24
$60.59
1주일 범위
$58.24
$61.69
52주 변동 폭
$46.01
$79.28
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
612-379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
TECH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
58.51 | 9.39B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
4D Advisors LLC Makes New $2.06 Million Investment in Bio-Techne Corp $TECH - MarketBeat
GMP Cytokine Market and Competition Outlook to 2031: Growing at 8.4% CAGR, Led by Bio-Techne, PeproTech, CellGenix Among OthersResearchAndMarkets.com - The AI Journal
Osterweis Capital Management Inc. Has $7.70 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Cerity Partners LLC Boosts Stake in Bio-Techne Corp $TECH - MarketBeat
Here’s Why BioTechne (TECH) Traded Lower in Q3 - Yahoo Finance
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology - Investing News Network
Bio-techne and Wyss Center partner to develop automated 3D multiomics - Investing.com
Bio-Techne (NASDAQ: TECH) and Wyss Geneva to develop automated 3D multiomics workflow - Stock Titan
Does Bio-Techne’s Recent Weakness Offer an Opportunity After Its Cell and Gene Therapy Push? - Yahoo Finance
Bio-Techne Announces Expanded Launch Of Next-Generation Leo System - Nasdaq
Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis - Investing News Network
Bio-techne ships enhanced Leo System with expanded detection capabilities - Investing.com
Bio-Techne (NASDAQ: TECH) debuts Leo system with dual-channel fluorescence - Stock Titan
Transcript : Bio-Techne Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-09-2025 09 - marketscreener.com
Arrowstreet Capital Limited Partnership Has $18.94 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Cresset Asset Management LLC Boosts Holdings in Bio-Techne Corp $TECH - MarketBeat
Brown Capital Management LLC Sells 94,825 Shares of Bio-Techne Corp $TECH - MarketBeat
1832 Asset Management L.P. Takes $7.72 Million Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corporation (TECH): A Bull Case Theory - Finviz
Norges Bank Buys New Stake in Bio-Techne Corp $TECH - MarketBeat
Russell Investments Group Ltd. Sells 23,984 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Holdings Reduced by Hsbc Holdings PLC - MarketBeat
How analysts revise price targets for Bio Techne Corporation (TE1) stockWeekly Market Report & Accurate Intraday Trading Signals - Newser
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp $TECH Position Increased by Granite Investment Partners LLC - MarketBeat
Can Bio Techne Corporation stock reach $100 price targetWeekly Profit Report & AI Forecast Swing Trade Picks - Newser
Will Bio Techne Corporation (TE1) stock gain from green policies2025 Volatility Report & Real-Time Chart Pattern Alerts - Newser
How Bio Techne Corporation stock compares to market leadersQuarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Edgestream Partners L.P. Has $11.81 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Prudential Financial Inc. Trims Holdings in Bio-Techne Corp $TECH - MarketBeat
Capital Fund Management S.A. Invests $4.89 Million in Bio-Techne Corp $TECH - MarketBeat
Mackenzie Financial Corp Raises Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Rhumbline Advisers Has $15.16 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Bought by JPMorgan Chase & Co. - MarketBeat
Grandeur Peak Global Advisors LLC Has $7.13 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
Charles Schwab Investment Management Inc. Boosts Position in Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation stock supported by strong cash flows2025 Major Catalysts & Advanced Technical Analysis Signals - BỘ NỘI VỤ
Bio-Techne Corp $TECH Shares Sold by Neuberger Berman Group LLC - MarketBeat
Legal & General Group Plc Cuts Position in Bio-Techne Corp $TECH - MarketBeat
XTX Topco Ltd Boosts Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne (TECH): Assessing Valuation After ACA Subsidy Extension Buzz Boosts Investor Sentiment - simplywall.st
Bio-Techne (TECH): Evaluating Valuation After ACA Subsidy Extension Boosts Market Sentiment - Yahoo Finance
Swiss National Bank Has $15.52 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Braces for a Biotech Funding Revival—Is a Major Upswing Ahead? - Smartkarma
SG Americas Securities LLC Sells 39,245 Shares of Bio-Techne Corp $TECH - MarketBeat
Ensign Peak Advisors Inc Trims Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Acquired by American Century Companies Inc. - MarketBeat
Rhenman & Partners Asset Management AB Takes Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Forecasts - Yahoo! Finance Canada
Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):